Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Vaccine|September 17, 2009
Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidateMeral Esen, Peter G Kremsner, Regina Schleucher, et al.British Journal of Haematology|June 25, 2016
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patientsHeiko-Manuel Teltschik, Frank Heinzelmann, Bernd Gruhn, et al.Stem Cells and Development|April 17, 2020
Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or ChemotherapyMichaela Döring, Torsten Kluba, Karin Melanie Cabanillas Stanchi, et al.British Journal of Haematology|June 29, 2006
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantationTobias Feuchtinger, Susanne Matthes-Martin, Celine Richard, et al.Frontiers in Immunology|July 30, 2019
Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote <i>ex vivo</i> Lysis of Leukemic Blasts in a CD1d-Dependent MannerSimona Jahnke, Hannes Schmid, Kathy-Ann Secker, et al.Oncoimmunology|July 9, 2015
Rapid generation of NY-ESO-1-specific CD4<sup>+</sup> T<sub>HELPER</sub>1 cells for adoptive T-cell therapySimone Kayser, Cristina Boβ, Judith Feucht, et al.British Journal of Haematology|March 5, 2014
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemiaPeter Lang, Heiko-Manuel Teltschik, Tobias Feuchtinger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantationVanya Icheva, Simone Kayser, Daniel Wolff, et al.Blood|July 14, 2010
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantationTobias Feuchtinger, Kathrin Opherk, Wolfgang A Bethge, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2018
Clearance of Treatment Refractory Adenoviremia via Adenovirus-specific Donor T-Cell Transfer During Aplasia After αβTCR-CD19-Depleted Stem Cell TransplantationKatharina L Gössling, Hiba Fouz, Olga Kyrillopoulou, et al.Pageof 5